Common use of No Further Authorizations or Approvals Required Clause in Contracts

No Further Authorizations or Approvals Required. No approval, authorization, consent or order of or filing with any federal, state, local or foreign governmental or regulatory commission, board, body, authority or agency, or of or with any self-regulatory organization or other non-governmental regulatory authority (including, without limitation, the Nasdaq Global Market), or approval of the stockholders of the Company is required in connection with the issuance and sale of the Shares or the consummation by the Company of the transactions contemplated hereby, other than (i) the registration of the Shares under the Securities Act , which has been effected (or, with respect to any registration statement to be filed hereunder pursuant to Rule 462(b) under the Act, will be effected in accordance herewith), (ii) any necessary qualification under the securities or blue sky laws of the various jurisdictions in which the Shares are being offered by the Agent, (iii) under the Conduct Rules of Financial Industry Regulatory Authority, Inc. (“FINRA”), (iv) any listing applications and related consents or any notices required by the Nasdaq Global Market in the ordinary course of the offering of the Shares or (v) filings with the Commission pursuant to Rule 424(b) under the Securities Act, except as have already been made, obtained or waived or where the failure to obtain any such approval, authorization, consent, order or filing would not impair the ability of the Company to issue and sell the Shares or to consummate the transactions contemplated by this Agreement.

Appears in 5 contracts

Samples: Open Market Sale Agreement (Selecta Biosciences Inc), Open Market Sale Agreement (Selecta Biosciences Inc), Sales Agreement (Selecta Biosciences Inc)

AutoNDA by SimpleDocs

No Further Authorizations or Approvals Required. No approval, authorization, consent or order of or filing with any federal, state, local or foreign governmental or regulatory commission, board, body, authority or agency, or of or with any self-regulatory organization or other non-governmental regulatory authority (including, without limitation, Nasdaq) having jurisdiction over the Nasdaq Global Market)Company, or approval of the stockholders of the Company Company, is required in connection with the issuance and sale of the Shares Securities and, upon exercise of the Pre-Funded Warrants, the issuance of the Warrant Shares, or the consummation by the Company of the transactions contemplated hereby, other than (i) the registration of the Shares Securities under the Securities Act Act, which has been effected (or, with respect to any registration statement to be filed hereunder pursuant to Rule 462(b) under the Securities Act, will be effected in accordance herewith), ; (ii) any necessary qualification under the securities or blue sky laws of the various jurisdictions in which the Shares Securities are being offered by the Agent, Underwriters; (iii) under the Conduct Rules of Financial Industry Regulatory Authority, Inc. (“FINRA”), ; (iv) any listing applications and related consents or any notices required by the Nasdaq Global Market in the ordinary course of the offering of the Shares or Securities; (v) filings with the Commission pursuant to Rule 424(b) under the Securities Act, ; (vi) filings with the Commission on Form 8-K with respect to the Underwriting Agreement and Exhibit 5 opinion; or (vii) except as otherwise have already been made, obtained or waived or where the failure to obtain any such approval, authorization, consent, order or filing would not impair the ability made as of the Company to issue and sell the Shares or to consummate the transactions contemplated by date of this Agreement.

Appears in 1 contract

Samples: Underwriting Agreement (Concert Pharmaceuticals, Inc.)

No Further Authorizations or Approvals Required. No approval, authorization, consent or order of or filing with any federal, state, local or foreign governmental or regulatory commission, board, body, authority or agency, or of or with any self-regulatory organization or other non-governmental regulatory authority (including, without limitation, Nasdaq) having jurisdiction over the Nasdaq Global Market)Company, or approval of the stockholders of the Company Company, is required in connection with the issuance and sale of the Shares or the consummation by the Company of the transactions contemplated hereby, other than (i) the registration of the Shares under the Securities Act Act, which has been effected (or, with respect to any registration statement to be filed hereunder pursuant to Rule 462(b) under the Securities Act, will be effected in accordance herewith), (ii) any necessary qualification under the securities or blue sky laws of the various jurisdictions in which the Shares are being offered by the Agent, (iii) under the Conduct Rules of Financial Industry Regulatory Authority, Inc. (“FINRA”), (iv) any listing applications and related consents or any notices required by the Nasdaq Global Market in the ordinary course of the offering of the Shares or Shares, (v) filings with the Commission pursuant to Rule 424(b) under the Securities Act, (vi) filings with the Commission on Form 8-K with respect to this Agreement and Exhibit 5 opinion, or (vii) except as otherwise have already been made, obtained or waived or where the failure to obtain any such approval, authorization, consent, order or filing would not impair the ability made as of the Company to issue and sell the Shares or to consummate the transactions contemplated by date of this Agreement.

Appears in 1 contract

Samples: Open Market Sale Agreement (Concert Pharmaceuticals, Inc.)

AutoNDA by SimpleDocs

No Further Authorizations or Approvals Required. No approval, authorization, consent or order of or filing with any federal, state, local or foreign governmental or regulatory commission, board, body, authority or agency, or of or with any self-regulatory organization or other non-governmental regulatory authority (including, without limitation, Nasdaq) having jurisdiction over the Nasdaq Global Market)Company, or approval of the stockholders of the Company Company, is required in connection with the issuance and sale of the Offered Shares or the consummation by the Company of the transactions contemplated hereby, other than (i) the registration of the Offered Shares under the Securities Act Act, which has been effected (or, with respect to any registration statement to be filed hereunder pursuant to Rule 462(b) under the Securities Act, will be effected in accordance herewith), ; (ii) any necessary qualification under the securities or blue sky laws of the various jurisdictions in which the Offered Shares are being offered by the Agent, Underwriters; (iii) under the Conduct Rules of Financial Industry Regulatory Authority, Inc. (“FINRA”), ; (iv) any listing applications and related consents or any notices required by the Nasdaq Global Market in the ordinary course of the offering of the Shares or Offered Shares; (v) filings with the Commission pursuant to Rule 424(b) under the Securities Act, ; (vi) filings with the Commission on Form 8-K with respect to the Underwriting Agreement and Exhibit 5 opinion; or (vii) except as otherwise have already been made, obtained or waived or where the failure to obtain any such approval, authorization, consent, order or filing would not impair the ability made as of the Company to issue and sell the Shares or to consummate the transactions contemplated by date of this Agreement.

Appears in 1 contract

Samples: Underwriting Agreement (Concert Pharmaceuticals, Inc.)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!